Navigation Links
STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Date:4/25/2012

MONROVIA, Calif., April 25, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) today announced that it will release its financial results for the first quarter ended March 30, 2012 on Wednesday, May 2, 2012 after the market close. The Company will host a conference call and webcast on Wednesday, May 2, 2012 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's first quarter 2012 results and recent corporate developments. The dial-in number for the conference call is 877-941-9205 for domestic participants and 480-629-9771 for international participants.

The Company will also be using slides to illustrate its first quarter results and operational progress. The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at www.staar.com.A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4531978#. An archived webcast will also be available at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902. 

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.  CONTACT:

Investors

MediaEVC Group

EVC GroupJenifer Kirtland

Chris GaleDoug Sherk

646-201-5431415-568-4887
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
2. STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash
3. STAAR Surgical Reports Progress on Japan Application for Approval of Visian Toric Implantable Collamer® Lens (TICL)
4. STAAR Surgical to Present at the 2011 Canaccord Genuity Growth Conference
5. STAAR Surgical Reports 19% Revenue Growth Second Quarter
6. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
7. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
8. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
9. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
10. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
11. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)...  Glenmark Pharmaceuticals, a global pharmaceutical company, today ... fixed-dose combination of mometasone furoate (25 mcg) and ... nasal spray being studied for the treatment of ... recently completed Phase 3 trial assessing the efficacy ... mometasone, olopatadine or placebo. "We continue ...
(Date:3/29/2017)... New York , March 29, 2017 /PRNewswire/ ... recently published a report, which provides an exhaustive ... to the study, nearly 242 companies are functional ... fragmented and competitive. With the leading companies, such ... Purdue Pharma LP, focusing aggressively on various marketing ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 2.87% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Hamlin Dental Group, multi-location dental ... offering laser dental treatments. Dental lasers are safe and effective options, and can be ... and can improve the overall quality of care. , Dr. Hamid Reza of Hamlin ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the official ... Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony on ... of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than 1,400 ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy ... meaning they either don’t have access to a health care facility or a pharmacy within ... regions of the United States or for many who are faced with health or personal ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... state legislatures and Congress to protect parental rights and civil liberties, and to ... in America. , The demonstration coincides with a press conference taking place Friday ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
Breaking Medicine News(10 mins):